Direkt zum Inhalt
Merck

Loratadine in the treatment of urticaria.

Clinical therapeutics (1997-03-01)
E W Monroe
ZUSAMMENFASSUNG

Urticaria is a common skin disease, which in its chronic form, is a very disturbing condition. Because histamine is the best-documented chemical mediator of urticaria, histamine-antagonists are the mainstay of therapy. First-generation antihistamines are limited by their tendency to produce sedation and anticholinergic side effects. Most of the newer second generation antihistamines compare well with the earlier agents in efficacy but are not limited by the same adverse side effects. Loratadine may be distinguished from other second-generation antihistamines by its pharmacodynamic profile, as well as its tolerability and safety.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Loratadin, ≥98% (HPLC), powder
USP
Loratadin, United States Pharmacopeia (USP) Reference Standard
Supelco
Loratadin, Pharmaceutical Secondary Standard; Certified Reference Material
Loratadin für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Loratadin, European Pharmacopoeia (EP) Reference Standard